Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model
<p><strong>Background</p></strong> The National Institute for Health and Care Excellence (NICE) recommends that people aged 60+ years with newly diagnosed diabetes and weight loss undergo abdominal imaging to assess for pancreatic cancer. More nuanced stratification could lea...
Main Authors: | Clift, AK, Tan, PS, Patone, M, Liao, W, Coupland, C, Bashford-Rogers, R, Sivakumar, S, Hippisley-Cox, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2024
|
Similar Items
-
Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
by: Tan, PS, et al.
Published: (2022) -
Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
by: Coupland Carol, et al.
Published: (2010-06-01) -
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study
by: Hippisley-Cox, J, et al.
Published: (2017) -
Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study
by: Hippisley-Cox, J, et al.
Published: (2017) -
Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population
by: Liao, W, et al.
Published: (2021)